Objective: To develop a new staging system for juvenile nasopharyngeal angiofibroma that reflects changes in surgical approaches (endonasal), route of intracranial extension, and the extent of vascular supply from the internal carotid artery.
fibromas are rare benign tumors that are almost exclusively found in male adolescents. They are characterized by high vascularity and locally aggressive growth with the potential for skull base erosion and intracranial extension. Common symptoms at presentation include nasal obstruction and epistaxis. Large tumors may also cause orbital displacement with diplopia, facial hypesthesia from trigeminal nerve compression, trismus, and facial deformity. Intracranial extension is seen in 10% to 20% of cases. 1 The preferred treatment of juvenile nasopharyngeal angiofibroma is complete surgical excision, with reported recurrence rates of 15% to 50%. 1, 2 A variety of open surgical approaches have been described: transpalatal, midfacial degloving, LeFort I osteotomies, lateral rhinotomy, transfacial, infratemporal fossa, and craniofacial approaches. Endoscopic transnasal approaches have largely replaced open approaches for small tumors 3 and may be combined with open approaches for larger tumors, including midfacial degloving approach with endoscopic excision. Treatment alternatives for large tumors that are deemed "inoperable" include radiation therapy and antiandrogen therapy. 4 Multiple staging systems have been proposed for juvenile nasopharyngeal angiofibroma ( Table 1) . [5] [6] [7] [8] [9] The common feature of these staging systems is that the tumor stage depends on the extent and sites of tumor involvement. Advanced stages are associated with skull base involvement and intracranial extension. Most of these staging systems were developed prior to the widespread adoption of endoscopic techniques, and thus the stages may not include important prognostic factors for endoscopic techniques. A major deficiency of existing staging systems is that they do not account for the route of intracranial extension and the vascularity of the tumor.
We performed a retrospective review of endoscopic surgical procedures for juvenile nasopharyngeal angiofibroma at our institution with the goals of evaluating prognostic factors for recurrence and morbidity and developing a new staging system that incorporates these factors and reflects changes in surgical management.
METHODS

PATIENTS
A retrospective review of surgical procedures performed for juvenile nasopharyngeal angiofibroma at the University of Pittsburgh Medical Center (UPMC) from 1998 through 2006 was previously performed 10 to compare the outcomes of open, endoscopic-assisted, and completely endoscopic surgery. Embolization was performed 1 day before surgery using standard techniques with a combination of small particles for the tumor bed and coils for the proximal feeding vessels. Preembolization and postembolization angiograms were reviewed for evidence of residual vascularity from the internal carotid artery (ICA). Vascularity from branches of the external carotid artery was effectively abolished with the embolization procedure (bilateral embolization of internal maxillary arteries, facial arteries, and ascending pharyngeal arteries as indicated). The degree of residual vascularity from the ICA was not quantified but was based on identifiable vessels coming from the artery.
We included additional patients with juvenile nasopharyngeal angiofibroma who underwent endoscopic surgery from 2007 to 2008. Patients in both series without blood loss data were excluded. This database was then used to stage patients using existing staging systems and the UPMC staging system. The tumor stage was correlated with outcome variables including blood loss, need for multiple operations, and recurrence. In patients undergoing planned multiple operations (staged surgery), estimated total operative blood loss from each operation was pooled. Staged surgical procedures were not considered as re- sidual or recurrent disease. Residual disease was defined as tumor remaining after definitive surgery and detectable on immediate postoperative scans and was initially managed with observation. Recurrent disease was defined as regrowth of tumor following a negative postoperative scan.
STAGING SYSTEM
The UPMC staging system for juvenile nasopharyngeal angiofibroma is given in Table 2 and Figure 1 . It acknowledges that paranasal sinus involvement is not an impediment to complete surgical excision. Stage I includes the smallest tumors with no significant extension beyond the site of origin and remain medial to the midpoint of the pterygopalatine space. Stage II tumors extend to the paranasal sinuses and lateral to the midpoint of the pterygopalatine space. Together, stages I and II can be considered minimal stage tumors. For this staging system, it is presumed that all but the smallest of tumors will have preoperative embolization of the internal maxillary artery and other contributing branches of the external carotid arterial system to devascularize the tumor and facilitate surgery. Tumors that are locally advanced with skull base erosion or extension to additional extracranial spaces, including orbit and infratemporal fossa, but no residual vascularity following embolization are stage III. Technically, the surgery required for a stage III tumor requires greater access and is more challenging but is not plagued by excessive bleeding. The tumor usually has a well-defined margin that easily separates from dura, periorbita, or muscle fascia. Stage IV and V tumors are characterized by residual vascularity from the intracranial circulation following embolization. True intracranial extension (stage V) is subdivided into medial (medial cavernous sinus) and lateral (middle fossa) routes of extension, since this has significant implications for surgical access, potential morbidity, and risk of residual disease. Medial extension is defined by tumor extension medial to the paraclival and cavernous segments of the ICA and can include extension into the cavernous sinus posterior to the ICA at the level of the pituitary gland. Lateral extension is defined by tumor extension to the middle cranial fossa superior to the petrous ICA and lateral to the paraclival and cavernous segments of the ICA. It may occur by direct extension with erosion of the floor of the middle cranial fossa or by extension through foramina (eg, foramen ovale, superior orbital fissure).
STATISTICAL ANALYSIS
Outcome variables and tumor stage were correlated using the Spearman correlation, with a significance level of .05 (GraphPad Prism software, version 4.0a for Macintosh; GraphPad Software Inc, La Jolla, California). Multiple operations and tumor stage were compared with a Fisher exact test. 
RESULTS
Thirty-five patients were included in this study and their clinical characteristics and UPMC tumor stage are summarized in Table 3 and Table 4 . Skull base erosion was observed in 74% of cases. Embolization of the external carotid artery tributaries was successful in all cases. Thus, following embolization, residual vascularity from identifiable tributaries of the ICA was seen in approximately 51% of patients.
The UPMC stage had the strongest correlation with intraoperative blood loss (PϽ.001) (Figure 2 ). In contrast to other staging systems, all patients with intraoperative blood loss greater then 1000 mL were only in the most advanced stages (IV and V).
Planned multiple operations were necessary in 9 of 35 patients (26%) to achieve complete tumor removal ( Table 3 ). The decision to stage an operation was based on the residual vascularity of the tumor following embolization and intraoperative blood loss. There was a good correlation between UPMC stage and the need for multiple operations (P Ͻ.001) ( Table 5) .
Residual disease was detected in 5 of 35 patients (14%) following surgery (Table 3 ). In 3 of these patients, the residual tumor remained stable on serial scans and further therapy was not necessary; 2 patients had additional surgery to achieve excision. Delayed recurrence was observed in 3 patients and all of these patients had additional surgery ( Table 3 ). The location of residual and recurrent tumor was in the intracranial component of the tumor in all cases. Five patients had tumor medial to the ICA, and 3 patients had tumor lateral to the ICA but in close proximity to cranial nerves. The need for multiple operations, whether staged, residual, or recurrent tumor, was highly correlated with UPMC stage (16 of 17 patients) ( Table 4) . Compared with other staging systems, the UPMC stage had the highest correlation with recurrent and residual tumor (7 of 8 patients with stages IV and V) ( Table 6 ).
COMMENT
The goals of treatment of juvenile nasopharyngeal angiofibroma are complete surgical excision with minimal morbidity and avoidance of radiation therapy. The choice of a surgical approach is designed to provide access to routes of tumor extension and control of the vascular supply of the tumor. Secondary goals of the surgical approach include avoidance of morbidity including blood loss and transfusion, cranial nerve injury, disruption of growth centers, cosmetic deformity, brain manipulation, and soft-tissue injury with associated pain. Successful surgery can obviate any consideration of radiation therapy with its attendant adverse effects and long-term risk of radiation-induced neoplasia in a young patient population.
The primary purpose of a tumor staging system is to provide prognostic information for treatment planning and counseling of patients. Secondary objectives include prediction of outcome (tumor recurrence) and promotion of uniform reporting in the medical literature to allow comparison of patient series with different tumor sites and treatments.
The UPMC staging system incorporates the following important prognostic factors that were not addressed by prior staging systems: route of extension and residual vascularity following embolization. The route of extension, including medial or lateral routes relative to the vertical segments of the ICA, is an important consideration in selecting the optimal surgical approach. For example, a tumor that extends medial to the ICA with invasion of the sella or cavernous sinus requires a midline approach. Tumors that extend laterally to the middle cranial fossa may be approached using an endonasal or an infratemporal approach.
The most important outcome in the operative period is blood loss and is the primary determinant of planned multiple surgical procedures. Operative deaths from hemorrhage undoubtedly occur and could perhaps be prevented with better prognostication and selection of alternate treatment strategies or referral to more experienced centers. A comparison of existing staging systems demonstrates no consistent relationship between tumor stage and the estimated blood loss. The morbidity of surgery is dependent on the stage of the tumor and the surgical approach. Observed morbidities in this patient population included trismus, infraorbital nerve hypesthesia, palatal hypesthesia, and epistaxis. No effects on facial growth were observed. We were unable to correlate these additional operative morbidities with tumor stage owing to the small number of patients with deficits and lack of consistent documentation.
The most important outcome in the postoperative period is tumor persistence or recurrence and may be a consequence of tumor location as well as vascularity. Almost all of the recurrences in our series occurred in patients with skull base involvement and residual vascularity. Dissection in proximity of the ICA when there is significant residual vascularity is more difficult owing to impaired visualization and surgeons are more likely to leave residual tumor that may be apparent on immediate postoperative scans or result in delayed recurrence. Compared with other staging systems, the UPMC staging system provided superior prediction of recurrent and residual disease. 
